keyword
https://read.qxmd.com/read/37297879/neutrophil-gelatinase-associated-lipocalin-ngal-in-patients-with-st-elevation-myocardial-infarction-and-its-association-with-acute-kidney-injury-and-mortality
#21
JOURNAL ARTICLE
Mathias Alexander Højagergaard, Rasmus Paulin Beske, Christian Hassager, Lene Holmvang, Lisette Okkels Jensen, Yacov Shacham, Martin Abild Stengaard Meyer, Jacob Eifer Moeller, Ole Kristian Lerche Helgestad, Peter Dall Mark, Rasmus Møgelvang, Martin Frydland
Neutrophil gelatinase-associated lipocalin (NGAL) is an inflammatory biomarker related to acute kidney injury (AKI). Including 1892 consecutive patients with ST-elevation myocardial infarction (STEMI), in which NGAL was measured in 1624 (86%) on admission and in a consecutive subgroup at 6-12 h (n = 163) and 12-24 h (n = 222) after admission, this study aimed to evaluate the prognostic value of NGAL in predicting AKI and mortality. Patients were stratified based on whether their admission NGAL plasma concentration was greater than or equal to/less than the median...
May 26, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37296695/evaluation-of-nag-ngal-and-kim-1-as-prognostic-markers-of-the-initial-evolution-of-kidney-transplantation
#22
JOURNAL ARTICLE
Guadalupe Tabernero, Moisés Pescador, Elena Ruiz Ferreras, Ana I Morales, Marta Prieto
Kidney transplantation is the best option for end-stage chronic kidney disease. Transplant viability is conditioned by drugs' nephrotoxicity, ischemia-reperfusion damage, or acute rejection. An approach to improve graft survival is the identification of post-transplant renal function prognostic biomarkers. Our objective was to study three early kidney damage biomarkers (N-acetyl-d-glucosaminidase, NAG; neutrophil gelatinase-associated lipocalin, NGAL; and kidney injury molecule-1, KIM-1) in the initial period after transplantation and to identify possible correlations with main complications...
May 25, 2023: Diagnostics
https://read.qxmd.com/read/37200285/use-of-admission-serum-neutrophil-gelatinase-associated-lipocalin-ngal-concentrations-as-a-marker-of-sepsis-and-outcome-in-neonatal-foals
#23
JOURNAL ARTICLE
Malene Laurberg, Claude Saegerman, Stine Jacobsen, Lise C Berg, Sigrid Hyldahl Laursen, Emma Hoeberg, Elaine Alexandra Sånge, Gaby van Galen
BACKGROUND: Equine neonatal sepsis can be challenging to diagnose and prognosticate. Neutrophil gelatinase-associated lipocalin (NGAL), a new marker of renal damage and inflammation, can potentially be helpful. OBJECTIVES: To evaluate NGAL in neonatal foals with sepsis, and assess its relation to outcome. ANIMALS: Foals ≤ 14 days, with admission blood analysis and stored serum. METHODS: NGAL was measured on stored serum from 91 foals...
2023: PloS One
https://read.qxmd.com/read/37127240/the-influence-of-body-mass-index-on-clinical-interpretation-of-established-and-novel-biomarkers-in-acute-heart-failure
#24
JOURNAL ARTICLE
Yu Horiuchi, Nicholas Wettersten, Dirk J van Veldhuisen, Christian Mueller, Richard Nowak, Christopher Hogan, Michael C Kontos, Chad M Cannon, Robert Birkhahn, Gary M Vilke, Niall Mahon, Julio Nuñez, Carlo Briguori, Stephen Duff, Patrick T Murray, Alan Maisel
BACKGROUND: Body mass index (BMI) is a known confounder for natriuretic peptides but its influence on other biomarkers is less well described. We investigated whether BMI interacts with biomarkers association with prognosis in patients with acute heart failure (AHF). METHODS AND RESULTS: B-type natriuretic peptide (BNP), high-sensitivity cardiac troponin I (hs-cTnI), galectin-3, serum neutrophil gelatinase associated lipocalin (sNGAL) and urine NGAL were measured serially in AHF patients during hospitalization in the AKINESIS study...
April 29, 2023: Journal of Cardiac Failure
https://read.qxmd.com/read/36979845/biomarkers-of-neutrophil-activation-in-patients-with-symptomatic-chronic-peripheral-artery-disease-predict-worse-cardiovascular-outcome
#25
JOURNAL ARTICLE
Giacomo Buso, Elisabetta Faggin, Alessandro Bressan, Silvia Galliazzo, Francesco Cinetto, Carla Felice, Michele Fusaro, Andreas Erdmann, Paolo Pauletto, Marcello Rattazzi, Lucia Mazzolai
Neutrophils play a role in cardiovascular (CV) disease. However, relatively scant evidence exists in the setting of peripheral artery disease (PAD). The aims of this study were to measure biomarkers of neutrophil activation in patients with symptomatic chronic PAD compared with healthy controls, to assess their association with PAD severity, and to evaluate their prognostic value in patients with PAD. The following circulating markers of neutrophil degranulation were tested: polymorphonuclear neutrophil (PMN) elastase, neutrophil gelatinase-associated lipocalin (NGAL), and myeloperoxidase (MPO)...
March 12, 2023: Biomedicines
https://read.qxmd.com/read/36930649/effect-of-antiretroviral-therapy-on-decreasing-arterial-stiffness-metabolic-profile-vascular-and-systemic-inflammatory-cytokines-in-treatment-na%C3%A3-ve-hiv-a-one-year-prospective-study
#26
JOURNAL ARTICLE
Pedro Martínez-Ayala, Guillermo Adrian Alanis-Sánchez, Monserrat Álvarez-Zavala, Karina Sánchez-Reyes, Vida Verónica Ruiz-Herrera, Rodolfo Ismael Cabrera-Silva, Luz Alicia González-Hernández, Carlos Ramos-Becerra, Ernesto Cardona-Muñoz, Jaime Federico Andrade-Villanueva
INTRODUCTION: Cardiovascular disease is a major cause of death among people living with HIV (PLH). Non-treated PLH show increased levels of inflammation and biomarkers of vascular activation, and arterial stiffness as a prognostic cardiovascular disease risk factor. We investigated the effect of one year of ART on treatment-naïve HIV(+) individuals on arterial stiffness and inflammatory and vascular cytokines. METHODS: We cross-sectionally compared aortic stiffness via tonometry, inflammatory, and vascular serum cytokines on treatment-naïve (n = 20) and HIV (-) (n = 9) matched by age, sex, metabolic profile, and Framingham score...
2023: PloS One
https://read.qxmd.com/read/36836567/biomarkers-as-prognostic-predictors-and-therapeutic-guide-in-critically-ill-patients-clinical-evidence
#27
REVIEW
Rosa Méndez Hernández, Fernando Ramasco Rueda
A biomarker is a molecule that can be measured in a biological sample in an objective, systematic, and precise way, whose levels indicate whether a process is normal or pathological. Knowing the most important biomarkers and their characteristics is the key to precision medicine in intensive and perioperative care. Biomarkers can be used to diagnose, in assessment of disease severity, to stratify risk, to predict and guide clinical decisions, and to guide treatments and response to them. In this review, we will analyze what characteristics a biomarker should have and how to ensure its usefulness, and we will review the biomarkers that in our opinion can make their knowledge more useful to the reader in their clinical practice, with a future perspective...
February 15, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36790467/biomarkers-of-egfr-decline-after-cardiac-surgery-in-children-findings-from-the-assess-aki-study
#28
JOURNAL ARTICLE
Christina de Fontnouvelle, Michael Zappitelli, Heather R Thiessen-Philbrook, Yaqi Jia, Paul L Kimmel, James S Kaufman, Prasad Devarajan, Chirag R Parikh, Jason H Greenberg
BACKGROUND: Children who require surgery for congenital heart disease have increased risk for long-term chronic kidney disease (CKD). Clinical factors as well as urine biomarkers of tubular health and injury may help improve the prognostication of estimated glomerular filtration rate (eGFR) decline. METHODS: We enrolled children from 1 month to 18 years old undergoing cardiac surgery in the ASSESS-AKI cohort. We used mixed-effect models to assess the association between urinary biomarkers (log2-transformed uromodulin, NGAL, KIM-1, IL-18, L-FABP) measured 3 months after cardiac surgery and cyanotic heart disease with the rate of eGFR decline at annual in-person visits over 4 years...
February 15, 2023: Pediatric Nephrology
https://read.qxmd.com/read/36763249/urine-neutrophil-gelatinase-associated-lipocalin-as-a-biomarker-of-acute-kidney-injury-and-prognosis-in-decompensated-chronic-liver-disease-a-prospective-study
#29
JOURNAL ARTICLE
Rohan Vijay Yewale, Balakrishnan Siddartha Ramakrishna, Giriprasad Venugopal, Babu Vinish Doraiswami, Kayalvizhi Rajini
BACKGROUND: Acute kidney injury (AKI) heralds deterioration in patients with decompensated chronic liver disease (DCLD). Serum creatinine (sCr), a component of the model for end-stage liver disease-sodium (MELD-Na) prognostic score, has limitations in patients with DCLD. We evaluated the prognostic role of urine neutrophil gelatinase-associated lipocalin (NGAL) in DCLD and its ability to sub-type AKI. METHODS: Total 147 consecutive patients hospitalized between June 2018 and June 2020 for complications of DCLD were evaluated...
February 10, 2023: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology
https://read.qxmd.com/read/36721033/euthyroid-sick-syndrome-and-its-association-with-complications-of-type-1-diabetes-mellitus-onset
#30
JOURNAL ARTICLE
Pierluigi Marzuillo, Dario Iafusco, Stefano Guarino, Anna Di Sessa, Angela Zanfardino, Alessia Piscopo, Caterina Luongo, Daniela Capalbo, Martina Verde, Francesca Aiello, Adalgisa Festa, Emanuele Miraglia Del Giudice, Anna Grandone
OBJECTIVE: To evaluate (i) the prevalence and association of euthyroid sick syndrome (ESS) [decreased FT3 and/or FT4 and normal/decreased TSH] with severity indexes of type 1 diabetes mellitus (T1DM) onset such as diabetic ketoacidosis (DKA) and kidney damage [acute kidney injury (AKI) based on KDIGO criteria, acute tubular necrosis (ATN), renal tubular damage (RTD)], (ii) relationship between clinical/metabolic parameters at T1DM onset and thyroid hormones, and (iii) ESS as a prognostic indicator of delayed recovery from kidney damage...
January 31, 2023: Pediatric Research
https://read.qxmd.com/read/36700431/improvement-in-renal-function-during-the-treatment-of-acute-decompensated-heart-failure-relationship-with-markers-of-renal-tubular-injury-and-prognostic-importance
#31
JOURNAL ARTICLE
Peter S Natov, Juan B Ivey-Miranda, Zachary L Cox, Julieta Moreno-Villagomez, Christopher Maulion, Lavanya Bellumkonda, Michael G Shlipak, Michelle M Estrella, Barry A Borlaug, Veena S Rao, Jeffrey M Testani
BACKGROUND: Improvement in renal function (IRF) in acute decompensated heart failure is associated with adverse outcomes. The mechanisms driving this paradox remain undefined. METHODS: Using the ROSE-AHF study (Renal Optimization Strategies Evaluation-Acute Heart Failure), 277 patients were grouped according to renal function, with IRF defined by a ≥20% increase (N=75), worsening renal function by a ≥20% decline (N=53), and stable renal function (SRF) by a <20% change (N=149) in estimated glomerular filtration rate between baseline and 72 hours...
March 2023: Circulation. Heart Failure
https://read.qxmd.com/read/36683554/urinary-biomarkers-to-predict-acute-kidney-damage-and-mortality-in-covid-19
#32
JOURNAL ARTICLE
Diana Racovitan, Maximilian Hogeweg, Adrian A Doevelaar, Maximilian Seidel, Benjamin Rohn, Sebastian Bettag, Sonja Rieckmann, Nina Babel, Felix S Seibert, Timm H Westhoff
INTRODUCTION: Acute kidney injury (AKI) is a frequent condition in patients hospitalized for COVID-19. There are only a few reports on the use of urinary biomarkers in COVID-19 and no data so far comparing the prognostic use of individual biomarkers in the prediction of adverse outcomes. MATERIALS AND METHODS: We performed a prospective mono-centric study on the value of urinary biomarkers in predicting the composite endpoint of a transfer to the intensive care unit, the need for renal replacement therapy, mechanical ventilation, and in-hospital mortality...
January 23, 2023: Clinical Nephrology
https://read.qxmd.com/read/36630924/urinary-biomarkers-of-tubular-health-and-risk-for-kidney-function-decline-or-mortality-in-diabetes
#33
JOURNAL ARTICLE
Teresa K Chen, Steven G Coca, Heather R Thiessen-Philbrook, Hiddo J L Heerspink, Wassim Obeid, Joachim H Ix, Linda F Fried, Joseph V Bonventre, Joe M El-Khoury, Michael G Shlipak, Chirag R Parikh
INTRODUCTION: Diabetes is a leading cause of end-stage kidney disease (ESKD). Biomarkers of tubular health may prognosticate chronic kidney disease (CKD) progression beyond estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR). METHODS: We examined associations of five urinary biomarkers of tubular injury and repair (NGAL, KIM-1, IL-18, MCP-1, YKL-40) with kidney function decline (first occurrence of a decrease in eGFR ≥30 mL/min/1...
2022: American Journal of Nephrology
https://read.qxmd.com/read/36286848/-urinary-biomarkers-of-kidney-injury-in-patients-treated-with-anti-vegf-drugs
#34
JOURNAL ARTICLE
K S Grechukhina, N V Chebotareva, L G Zhukova, T V Androsova, V V Karpov, T N Krasnova
BACKGROUND: Antiangiogenic drugs are widely used in oncological practice and are aimed at inhibiting angiogenesis. Despite the high antitumor efficacy, their use may be limited by nephrotoxicity, and therefore the search for early biomarkers of kidney damage remains relevant, which will preserve a favorable safety profile of therapy. AIM: To determine urinary biomarkers of tubular and podocyte damage in patients receiving treatment with antiangiogenic drugs. MATERIALS AND METHODS: The study included patients (n=50) who received intravenous anti-VEGF drugs (aflibercept, bevacizumab, ramucirumab) in various chemotherapy regimens...
August 4, 2022: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/36248749/tissue-expression-of-neutrophil-gelatinase-associated-lipocalin-and-kidney-injury-molecule-1-in-breast-cancers
#35
JOURNAL ARTICLE
Gülden Diniz, Ayşe Gül Pulular, Dudu Solakoğlu Kahraman, Umut Varol, Sevil Sayhan, Duygu Ayaz, Cem Karaali
Objective: Breast cancer is the most common cancer among women worldwide. Neutrophil gelatinase-associated lipocalin (NGAL) has important roles in immunity, cell proliferation, and carcinogenesis. Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein also known as hepatitis A virus cellular receptor 1 and T-cell immunoglobulin and mucin, has restricted expression in immune cells and healthy epithelial cells, but it is up-regulated in several human cancers. The aim of this study was to determine the prognostic values of NGAL and KIM-1 expression in tumor cells and to detect the presence of NGAL-positive neutrophils (PNL) in the tumor microenvironment...
October 2022: European Journal of Breast Health
https://read.qxmd.com/read/36233836/predictive-and-prognostic-value-of-serum-neutrophil-gelatinase-associated-lipocalin-for-contrast-induced-acute-kidney-injury-and-long-term-clinical-outcomes-after-percutaneous-coronary-intervention
#36
JOURNAL ARTICLE
Jaeho Byeon, Ik Jun Choi, Dongjae Lee, Youngchul Ahn, Mi-Jeong Kim, Doo Soo Jeon
Neutrophil gelatinase-associated lipocalin (NGAL) has been proposed as an early marker for estimating the risk of contrast-induced acute kidney injury (CI-AKI). However, the predictive value of baseline serum NGAL levels for CI-AKI remains unclear. Serum NGAL was measured before percutaneous coronary intervention in 633 patients with coronary artery disease. The primary clinical endpoints were a composite of major adverse cardiac and cerebrovascular events (MACCEs; cardiac death, myocardial infarction, stroke, and any revascularization)...
October 10, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/36233628/current-insights-on-biomarkers-in-lupus-nephritis-a-systematic-review-of-the-literature
#37
REVIEW
Leonardo Palazzo, Julius Lindblom, Chandra Mohan, Ioannis Parodis
Lupus nephritis (LN) is a major cause of morbidity and mortality among patients with systemic lupus erythematosus (SLE). However, promising emerging biomarkers pave the way toward an improved management of patients with LN. We have reviewed the literature over the past decade, and we herein summarise the most relevant biomarkers for diagnosis, monitoring, and prognosis in LN. An initial systematic search of Medline was conducted to identify pertinent articles. A total of 104 studies were selected to be included in this review...
September 28, 2022: Journal of Clinical Medicine
https://read.qxmd.com/read/36227516/piro-cic-model-can-predict-mortality-and-futility-of-care-in-critically-ill-cirrhosis-patients-in-the-intensive-care-unit
#38
JOURNAL ARTICLE
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Harsh Vardhan Tevethia, Shiv Kumar Sarin
BACKGROUND: Dynamic assessment of critically ill patients with cirrhosis (CICs) is required for accurate prognostication. OBJECTIVE: Development of a dynamic model for prediction of mortality and decision on futility of care in CICs. DESIGN AND SETTING: In a prospective cohort study, we developed the PIRO-CIC model (predisposition, injury, response, organ failure for critically ill cirrhotics)] in a derivative cohort (n = 360) and validated it (n = 240) for patients admitted to the Liver ICU...
October 13, 2022: Hepatology International
https://read.qxmd.com/read/36211450/bioinformatic-analysis-of-the-lcn2-slc22a17-mmp9-network-in-cancer-the-role-of-dna-methylation-in-the-modulation-of-tumor-microenvironment
#39
JOURNAL ARTICLE
Saverio Candido, Barbara Tomasello, Alessandro Lavoro, Luca Falzone, Giuseppe Gattuso, Angela Russo, Sabrina Paratore, James A McCubrey, Massimo Libra
Several features of cancer cells such as proliferation, invasion, metastatic spreading, and drug resistance are affected by their interaction with several tumor microenvironment (TME) components, including neutrophil gelatinase-associated lipocalin (NGAL), solute carrier family 22 member 17 (SLC22A17), and matrix metallopeptidase 9 (MMP9). These molecules play a key role in tumor growth, invasion, and iron-dependent metabolism of cancer cells. However, the precise epigenetic mechanisms underlying the gene regulation of Lipocalin 2 ( LCN2 ), SLC22A17 , and MMP9 in cancer still remain unclear...
2022: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/36160364/diagnostic-and-prognostic-role-of-serum-omentin-and-ngal-levels-in-egyptian-breast-cancer-patients
#40
JOURNAL ARTICLE
Al-Shimaa Mahmoud Abas, Mohamed H Sherif, Sara A Elmoneam Farag
Background: Breast cancer (BC) is globally the main cause of cancer-related deaths in women. Tumor biomarkers have significant role in diagnosis and predicting the prognosis and decide the specific therapy to each patient. Aim: In this study, we investigated whether omentin and NGAL levels were altered in patients with breast cancer and the relationship between these markers and their clinicopathological parameters. Subjects and Methods . This study included 120 patients with breast cancer and 30 healthy individuals served as controls...
2022: International Journal of Breast Cancer
keyword
keyword
75479
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.